in this issue
Chemical Week Magazine :: Newsbriefs
BASF closes deal
8:43 AM MST | February 8, 2013
BASF says it has completed the previously announced acquisition of Pronova BioPharma (Lysaker, Norway), a pioneer in the fields of researching, developing, and manufacturing omega-3 fatty acids. BASF held 98.19% of Pronova on 31 January and launched a compulsory acquisition process, or squeeze-out, to acquire the remaining Pronova shares at the voluntary offer price of 13.50 Norwegian kroner/share ($2.48). BASF says it will fully integrate Pronova into its nutrition and health division, and Pronova will become a key part of BASFâ€™s omega-3...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee